LivaNova (LIVN) Baird 2024 Global Healthcare Conference summary

Leadership focus and organizational development

• Emphasis on talent development, with key leadership appointments in cardiopulmonary and innovation roles.

• Building a benchmark innovation team, including new leaders in R&D and business development.

• Focus on culture, engagement, and alignment to strategy to drive execution.

Execution and growth drivers

• Achieved six quarters of double-digit growth, driven by focused execution and supply chain improvements.

• Market share gains in cardiopulmonary disposables due to competitor constraints and capacity expansion.

• Pricing optimization and manufacturing excellence are key levers for sustaining growth.

Strategic outlook and future planning

• Strategy centers on maximizing core growth (epilepsy and cardiopulmonary), expanding into adjacencies (depression, sleep apnea), and defining the next growth chapter.

• A long-term plan through 2030 will be shared, with a three-year and longer-term chapter, and an analyst day planned for the first half of next year.

• Aspiration to become a benchmark med tech company, with above-market growth, margin expansion, and EPS improvement as key metrics.